$142 Million is the total value of Birchview Capital, LP's 60 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 13.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | BRISTOL-MYERS SQUIBB CO | $51,738,000 | -7.7% | 727,785 | 0.0% | 36.43% | -10.6% | |
| AZYO | AZIYO BIOLOGICS INC | $10,210,000 | +1.8% | 1,418,123 | 0.0% | 7.19% | -1.4% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $9,053,000 | +9.0% | 85,240 | 0.0% | 6.38% | +5.5% | |
| PRTA | Buy | PROTHENA CORP PLC | $7,212,000 | +159.1% | 118,945 | +16.0% | 5.08% | +150.8% |
| QDEL | QUIDELORTHO CORP | $4,382,000 | -26.5% | 61,306 | 0.0% | 3.09% | -28.8% | |
| ACAD | ACADIA PHARMACEUTICALS INC | $4,080,000 | +16.1% | 249,400 | 0.0% | 2.87% | +12.4% | |
| OVV | OVINTIV INC | $3,873,000 | +4.1% | 84,200 | 0.0% | 2.73% | +0.7% | |
| AXDX | ACCELERATE DIAGNOSTICS INC | $3,424,000 | +53.1% | 2,252,388 | 0.0% | 2.41% | +48.3% | |
| UTHR | UNITED THERAPEUTICS CORP | $3,141,000 | -11.1% | 15,000 | 0.0% | 2.21% | -14.0% | |
| BDSX | Buy | BIODESIX INC | $3,010,000 | +2.8% | 2,370,071 | +30.8% | 2.12% | -0.5% |
| CLR | CONTINENTAL RESOURCES INC | $2,579,000 | +2.2% | 38,600 | 0.0% | 1.82% | -1.0% | |
| FHTX | Sell | FOGHORN THERAPEUTICS INC | $2,272,000 | -41.4% | 264,843 | -7.0% | 1.60% | -43.2% |
| ALBO | Buy | ALBIREO PHARMA INC | $2,265,000 | +0.9% | 117,000 | +3.5% | 1.60% | -2.3% |
| BHVN | Sell | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | $2,227,000 | +1.9% | 14,730 | -1.8% | 1.57% | -1.4% |
| HROW | HARROW HEALTH INC | $2,173,000 | +65.9% | 180,000 | 0.0% | 1.53% | +60.5% | |
| MASI | MASIMO CORP | $2,157,000 | +8.0% | 15,280 | 0.0% | 1.52% | +4.5% | |
| PHR | PHREESIA INC | $2,107,000 | +1.9% | 82,700 | 0.0% | 1.48% | -1.3% | |
| GOSS | GOSSAMER BIO INC | $1,906,000 | +43.1% | 159,088 | 0.0% | 1.34% | +38.5% | |
| Buy | VENTYX BIOSCIENCES INC | $1,571,000 | +288.9% | 45,000 | +36.4% | 1.11% | +276.2% | |
| KPTI | KARYOPHARM THERAPEUTICS INC | $1,471,000 | +21.1% | 269,332 | 0.0% | 1.04% | +17.2% | |
| CORT | CORCEPT THERAPEUTICS INC | $1,282,000 | +7.8% | 50,000 | 0.0% | 0.90% | +4.4% | |
| INBX | INHIBRX INC | $1,265,000 | +58.1% | 70,448 | 0.0% | 0.89% | +53.1% | |
| CYTK | CYTOKINETICS INC | $1,211,000 | +23.3% | 25,000 | 0.0% | 0.85% | +19.5% | |
| AVEO | AVEO PHARMACEUTICALS INC | $1,152,000 | +25.5% | 140,000 | 0.0% | 0.81% | +21.4% | |
| ALKS | ALKERMES PLC | $1,117,000 | -25.0% | 50,000 | 0.0% | 0.79% | -27.4% | |
| DOCGO INC | $1,091,000 | +39.0% | 110,000 | 0.0% | 0.77% | +34.5% | ||
| CCXI | CHEMOCENTRYX INC | $1,033,000 | +108.3% | 20,000 | 0.0% | 0.73% | +101.4% | |
| ETRN | EQUITRANS MIDSTREAM CORPORATIO | $995,000 | +17.6% | 133,050 | 0.0% | 0.70% | +14.0% | |
| 2SEVENTY BIO INC | $871,000 | +10.3% | 59,833 | 0.0% | 0.61% | +6.6% | ||
| PXD | PIONEER NATURAL RESOURCES CO | $823,000 | -2.9% | 3,800 | 0.0% | 0.58% | -6.0% | |
| APLS | APELLIS PHARMACEUTICALS INC | $820,000 | +51.0% | 12,000 | 0.0% | 0.58% | +46.1% | |
| NARI | INARI MEDICAL INC | $726,000 | +6.8% | 10,000 | 0.0% | 0.51% | +3.2% | |
| IMGN | IMMUNOGEN INC | $717,000 | +6.2% | 150,000 | 0.0% | 0.50% | +2.9% | |
| ARVN | ARVINAS INC | $667,000 | +5.7% | 15,000 | 0.0% | 0.47% | +2.4% | |
| BLUE | BLUEBIRD BIO INC | $620,000 | +52.7% | 98,000 | 0.0% | 0.44% | +48.1% | |
| KALV | KALVISTA PHARMACEUTICALS INC | $580,000 | +47.2% | 40,000 | 0.0% | 0.41% | +42.2% | |
| IRTC | IRHYTHM TECHNOLOGIES INC | $501,000 | +16.0% | 4,000 | 0.0% | 0.35% | +12.4% | |
| GTHX | G1 THERAPEUTICS INC | $500,000 | +152.5% | 40,000 | 0.0% | 0.35% | +144.4% | |
| SILK | SILK ROAD MEDICAL INC | $450,000 | +23.6% | 10,000 | 0.0% | 0.32% | +19.6% | |
| ISEE | Buy | IVERIC BIO INC | $449,000 | +211.8% | 25,000 | +66.7% | 0.32% | +201.0% |
| NKTR | NEKTAR THERAPEUTICS | $410,000 | -15.6% | 128,000 | 0.0% | 0.29% | -18.4% | |
| SLNO | Sell | SOLENO THERAPEUTICS INC | $409,000 | -39.9% | 245,127 | -93.3% | 0.29% | -41.8% |
| FOLD | AMICUS THERAPEUTICS INC | $397,000 | -2.7% | 38,000 | 0.0% | 0.28% | -5.7% | |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $385,000 | +32.3% | 30,000 | 0.0% | 0.27% | +27.8% | |
| XENE | XENON PHARMACEUTICALS INC | $361,000 | +18.8% | 10,000 | 0.0% | 0.25% | +14.9% | |
| CGEM | Sell | CULLINAN MANAGEMENT INC | $322,000 | -44.3% | 25,114 | -44.3% | 0.23% | -46.0% |
| PTGX | PROTAGONIST THERAPEUTICS INC | $320,000 | +6.3% | 38,000 | 0.0% | 0.22% | +2.7% | |
| XNCR | XENCOR INC | $320,000 | -5.0% | 12,300 | 0.0% | 0.22% | -8.2% | |
| SRPT | New | SAREPTA THERAPEUTICS INC | $276,000 | – | 2,500 | +100.0% | 0.19% | – |
| BCRX | BIOCRYST PHARMACEUTICALS INC | $252,000 | +18.9% | 20,000 | 0.0% | 0.18% | +14.9% | |
| STOK | STOKE THERAPEUTICS INC | $193,000 | -2.5% | 15,000 | 0.0% | 0.14% | -5.6% | |
| IFRX | INFLARX NV | $185,000 | +81.4% | 70,000 | 0.0% | 0.13% | +75.7% | |
| CNCE | CONCERT PHARMACEUTICALS INC | $134,000 | +59.5% | 20,000 | 0.0% | 0.09% | +54.1% | |
| ATEC | New | ALPHATEC HOLDINGS INC | $87,000 | – | 10,000 | +100.0% | 0.06% | – |
| YTEN | YIELD10 BIOSCIENCE INC | $56,000 | +33.3% | 18,750 | 0.0% | 0.04% | +25.8% | |
| LSF | LAIRD SUPERFOOD INC | $51,000 | -3.8% | 28,000 | 0.0% | 0.04% | -7.7% | |
| ANGN | ANGION BIOMEDICA CORP | $50,000 | -19.4% | 54,392 | 0.0% | 0.04% | -22.2% | |
| CFRX | CONTRAFECT CORP | $34,000 | -94.5% | 200,000 | 0.0% | 0.02% | -94.6% | |
| SIEN | SIENTRA INC | $26,000 | -23.5% | 40,000 | 0.0% | 0.02% | -28.0% | |
| AWH | Sell | ASPIRA WOMEN'S HEALTH INC | $22,000 | -55.1% | 60,070 | -27.7% | 0.02% | -58.3% |
| BIIB | Exit | BIOGEN INC | $0 | – | 0 | +100.0% | 0.00% | – |
| AKBA | Exit | AKEBIA THERAPEUTICS INC | $0 | – | 0 | +100.0% | 0.00% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | 0 | +100.0% | 0.00% | – |
| VNDA | Exit | VANDA PHARMACEUTICALS INC | $0 | – | 0 | +100.0% | 0.00% | – |
| ZNTL | Exit | ZENTALIS PHARMACEUTICALS INC | $0 | – | -8,000 | -100.0% | -0.16% | – |
| TPTX | Exit | TURNING POINT THERAPEUTICS INC | $0 | – | -8,000 | -100.0% | -0.44% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2022-11-28
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACCELERATE DIAGNOSTICS INC | 36 | Q3 2023 | 34.6% |
| QUIDELORTHO CORP | 36 | Q3 2023 | 8.6% |
| MASIMO CORP | 36 | Q3 2023 | 2.2% |
| PIONEER NATURAL RESOURCES CO (PXD) | 36 | Q3 2023 | 0.7% |
| XENCOR INC | 35 | Q3 2023 | 0.4% |
| NEUROCRINE BIOSCIENCES INC | 33 | Q3 2023 | 7.4% |
| CORCEPT THERAPEUTICS INC | 32 | Q3 2023 | 1.2% |
| BIOGEN INC | 31 | Q2 2022 | 3.1% |
| CONTRAFECT CORP | 30 | Q3 2022 | 1.6% |
| YIELD10 BIOSCIENCE INC | 26 | Q3 2023 | 0.6% |
View Birchview Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SOLENO THERAPEUTICS INC | March 19, 2019 | 742,635 | 2.3% |
| YIELD10 BIOSCIENCE, INC. | December 29, 2017 | 186,079 | 2.2% |
| HANSEN MEDICAL INC | February 16, 2016 | ? | ? |
| METABOLIX, INC. | June 23, 2015 | 749,696 | 2.8% |
View Birchview Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3/A | 2024-02-20 |
| 4/A | 2024-02-20 |
| SC 13G/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-04-07 |
| 4 | 2023-03-27 |
| 3 | 2023-02-13 |
View Birchview Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.